Big pharma giant Pfizer is now betting on oncology since demand for its Covid-19 'vaccines' has collapsed.
Pfizer is focussed on the cancer treatment market now that the Covid pandemic is over and demand for the vaccines and coronavirus drugs are falling, CEO Albert Bourla said.
How very convenient now that cancer rates have suddenly started to soar.
RT reports: The company expects to score big on "Blockbuster" cancer drugs, Bourla said, as the pharma giant seeks to reverse its post-Covid business decline.
In 2022 alone, Pfizer's total sales amounted to $157 billion, with its Covid vaccine accounting for $37.8 billion and its antiviral treatment pill, Paxlovid, bringing in another $18.9 billion.
"Oncology, it is our new Covid," the Pfizer CEO said.
Pfizer announced its shift toward cancer treatment in late 2023.
https://thepeoplesvoice.tv/pfizer-ceo-says-cancer-is-our-new-covid/
No comments:
Post a Comment